Loading…
Cardiovascular Effects of Carbamazepine Toxicity
Study objective: To evaluate the cardiovascular effects of carbamazepine in patients presenting to the emergency department. Design: A retrospective case series from February 1, 1985, to July 30, 1993. Setting: Six urban EDs. Participants: Seventy-two adult and pediatric patients with serum carbamaz...
Saved in:
Published in: | Annals of emergency medicine 1995-05, Vol.25 (5), p.631-635 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Study objective: To evaluate the cardiovascular effects of carbamazepine in patients presenting to the emergency department.
Design: A retrospective case series from February 1, 1985, to July 30, 1993.
Setting: Six urban EDs.
Participants: Seventy-two adult and pediatric patients with serum carbamazepine concentrations greater than 12 μg/ml and concurrent 12-lead ECGs.
Results: The mean carbamazepine level was 24 μg/ml (range, 12.6 to 55 μg/ml). Minor ECG abnormalities were noted but no clinically significant arrhythmias were found. No correlation was found between carbamazepine concentration and heart rate or PR, QRS, or corrected QT intervals. Four adult patients had transient hypotension.
Conclusion: Clinically significant cardiovascular toxicity occurs rarely in patients with toxic carbamazepine concentrations. ECG findings do not correlate with serum carbamazepine concentration.
[Apfelbaum JD, Caravati EM, Kerns WP II, Bossart PJ, Larsen G: Cardiovascular effects of carbamazepine toxicity.
Ann Emerg Med May 1995;25:631-635.] |
---|---|
ISSN: | 0196-0644 1097-6760 |
DOI: | 10.1016/S0196-0644(95)70176-1 |